Somatic mutations of BRCA1 and BRCA2 were significantly associated with HRD in BRCA, OV, and BLCA, and lung squamous cell carcinoma (LUSC) (FDR < 0.002, Table 1). Here, BRCA2 is linked to bladder transitional cell carcinoma.